The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder

NCT00719706 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: acetyl-l-carnitine PLUS alpha-lipoic acide
DRUG: Placebo

Sponsor

Mclean Hospital

Collaborators

[object Object]